Antioxidants and Biomarkers of Oxidative Stress in Preterm Infants with Symptomatic Patent Ductus Arteriosus

American Journal of Perinatology

Volumn 32, Issue 9, 2015, Pages 895-904

  Inayat, Musaddaq ^a   Bany Mohammed, Fayez ^a   Valencia, Arwin ^b   Tay, Ching ^b   Jacinto, Josefina ^b   Aranda, Jacob V ^c,d   Beharry, Kay D ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d Department of Depression Evaluation Service   (United States)

Author keywords

antioxidant; oxidative stress; patent ductus arteriosus; premature infants

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CATALASE; IBUPROFEN; INDOMETACIN; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE; THROMBOXANE B2; ANTIOXIDANT; BIOLOGICAL MARKER; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN URINE LEVEL; URINALYSIS; BLOOD; DRUG EFFECTS; DUCTUS ARTERIOSUS, PATENT; LIGATION; NEWBORN; OXIDATIVE STRESS; URINE;

ANTIOXIDANTS; BIOMARKERS; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LIGATION; MALE; OXIDATIVE STRESS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84938201840     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1544948     Document Type: Article

References (50)

1. Capozzi G., Santoro G. Patent ductus arteriosus: patho-physiology, hemodynamic effects and clinical complications. J Matern Fetal Neonatal Med: 2011; 24 01 15 16
2. Watterberg K. L., Scott S. M., Backstrom C., Gifford K. L., Cook K. L. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics: 2000; 105 2 320 324
3. Shimada S., Kasai T., Konishi M., Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr: 1994; 125 2 270 277
4. Fowlie P. W. Managing the baby with a patent ductus arteriosus. More questions than answers? Arch Dis Child Fetal Neonatal Ed: 2005; 90 3 F190
5. Van Overmeire B., Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med: 2005; 10 2 177 184
6. Reyes J. L., Aldana I., Barbier O., Parrales A. A., Melendez E. Indomethacin decreases furosemide-induced natriuresis and diuresis on the neonatal kidney. Pediatr Nephrol: 2006; 21 11 1690 1697
7. Ohlsson A., Walia R., Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev: 2008; 23 1 CD003481
8. Mosalli R., Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. (Review) Cochrane Database Syst Rev: 2008; 1 1 CD006181
9. Malviya M., Ohlsson A., Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. (Review) Cochrane Database Syst Rev: 2008; 23 1 CD003951
10. Benitz W. E. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol: 2010; 30 4 241 252
11. Clyman R. I., Couto J., Murphy G. M. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol: 2012; 36 2 123 129
12. Fay F. S. Guinea pig ductus arteriosus. I. Cellular and metabolic basis for oxygen sensitivity. Am J Physiol: 1971; 221 2 470 479
13. Reeve H. L., Tolarova S., Nelson D. P., Archer S., Weir E. K. Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol: 2001; 533 (Pt 1): 253 261
14. Olschewski A., Hong Z., Peterson D. A., Nelson D. P., Porter V. A., Weir E. K. Opposite effects of redox status on membrane potential, cytosolic calcium, and tone in pulmonary arteries and ductus arteriosus. Am J Physiol Lung Cell Mol Physiol: 2004; 286 1 L15 L22
15. Weir E. K., Obreztchikova M., Vargese A., Cabrera J. A., Peterson D. A., Hong Z. Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus. Br J Pharmacol: 2008; 155 3 300 307
16. Greyner H., Dzialowski E. M. Mechanisms mediating the oxygen-induced vasoreactivity of the ductus arteriosus in the chicken embryo. Am J Physiol Regul Integr Comp Physiol: 2008; 295 5 R1647 R1659
17. Cogolludo A. L., Moral-Sanz J., van der Sterren S., et al. Maturation of O2 sensing and signaling in the chicken ductus arteriosus. Am J Physiol Lung Cell Mol Physiol: 2009; 297 4 L619 L630
18. Auten R. L., Davis J. M. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res: 2009; 66 2 121 127
19. Michelakis E. D., Rebeyka I., Wu X., et al. O2 sensing in the human ductus arteriosus: regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res: 2002; 91 6 478 486
20. Andriantsitohaina R., Duluc L., García-Rodríguez J. C., et al. Systems biology of antioxidants. Clin Sci (Lond): 2012; 123 3 173 192
21. Hsu J-H, Oishi P., Wiseman D. A., et al. Nitric oxide alterations following acute ductal constriction in the fetal lamb: a role for superoxide. Am J Physiol Lung Cell Mol Physiol: 2010; 298 6 L880 L887
22. Georgeson G. D., Szony B. J., Streitman K., et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol: 2002; 103 2 136 139
23. Nassi N., Ponziani V., Becatti M., Galvan P., Donzelli G. Anti-oxidant enzymes and related elements in term and preterm newborns. Pediatr Int: 2009; 51 2 183 187
24. Perrone S., Negro S., Tataranno M. L., Buonocore G. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med: 2010; 23 03 63 65
25. Ballard J. L., Khoury J. C., Wedig K., Wang L., Eilers-Walsman B. L., Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr: 1991; 119 3 417 423
26. Clerch L. B., Massaro D. Rat lung antioxidant enzymes: differences in perinatal gene expression and regulation. Am J Physiol: 1992; 263 4, Pt 1 L466 L470
27. Clyman R., Cassady G., Kirklin J. K., Collins M., Philips J. B. III. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr: 2009; 154 6 873 876
28. Chorne N., Leonard C., Piecuch R., Clyman R. I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics: 2007; 119 6 1165 1174
29. Frank L., Groseclose E. E. Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res: 1984; 18 3 240 244
30. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal: 2011; 15 6 1583 1606
31. Hamrick S. EG, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics: 2010; 125 5 1020 1030
32. Weir E. K., López-Barneo J., Buckler K. J., Archer S. L. Acute oxygen-sensing mechanisms. N Engl J Med: 2005; 353 19 2042 2055
33. Weir E. K., Hong Z., Porter V. A., Reeve H. L. Redox signaling in oxygen sensing by vessels. Respir Physiol Neurobiol: 2002; 132 1 121 130
34. Weir E. K., Archer S. L. The role of redox changes in oxygen sensing. Respir Physiol Neurobiol: 2010; 174 3 182 191
35. Thébaud B., Michelakis E. D., Wu X. C., et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation: 2004; 110 11 1372 1379
36. Kajimoto H., Hashimoto K., Bonnet S. N., et al. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation: 2007; 115 13 1777 1788
37. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res: 2004; 38 2 105 122
38. Praticò D. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis: 1999; 147 1 1 10
39. Longini M., Perrone S., Vezzosi P., et al. Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure. Pediatr Nephrol: 2011; 26 1 105 109
40. Clyman R. I., Waleh N., Black S. M., Riemer R. K., Mauray F., Chen Y. Q. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res: 1998; 43 5 633 644
41. Coceani F., Kelsey L., Seidlitz E. Occurrence of endothelium-derived relaxing factor-nitric oxide in the lamb ductus arteriosus. Can J Physiol Pharmacol: 1994; 72 1 82 88
42. Coceani F., Huhtanen D., Hamilton N. C., Bishai I., Olley P. M. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol: 1986; 64 6 737 744
43. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A: 1993; 90 24 11693 11697
44. Mueed I., Tazzeo T., Liu C., et al. Isoprostanes constrict human radial artery by stimulation of thromboxane receptors, Ca2+ release, and RhoA activation. J Thorac Cardiovasc Surg: 2008; 135 1 131 138
45. Habib A., Badr K. F. Molecular pharmacology of isoprostanes in vascular smooth muscle. Chem Phys Lipids: 2004; 128 1-2 69 73
46. Fox J. J., Ziegler J. W., Ivy D. D., Halbower A. C., Kinsella J. P., Abman S. H. Role of nitric oxide and cGMP system in regulation of ductus arteriosus tone in ovine fetus. Am J Physiol: 1996; 271 (6, Pt 2): H2638 H2645
47. Momma K., Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res: 1999; 46 3 311 315
48. Kajino H., Chen Y. Q., Chemtob S., Waleh N., Koch C. J., Clyman R. I. Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening. Am J Physiol Regul Integr Comp Physiol: 2000; 279 1 R278 R286
49. Takizawa T., Kihara T., Kamata A., Yamamoto M., Arishima K. Role of nitric oxide in regulating the ductus arteriosus caliber in fetal rats. J Vet Med Sci: 2000; 62 7 707 710
50. Seyberth H. W., Müller H., Ulmer H. E., Wille L. Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus. Pediatr Res: 1984; 18 6 520 524